What should we expect from multiple sclerosis therapy? Results of an integrated analysis of delayed-release dimethyl fumarate pivotal trials. [electronic resource]
Producer: 20180319Description: 661-662 p. digitalISSN:- 1468-1331
No physical items for this record
Publication Type: Editorial; Comment
There are no comments on this title.
Log in to your account to post a comment.